#GlaxoSmithKline

Yonhap Infomax Newsinfomaxkorea
2025-04-07

ABL Bio secures major $3.4 billion technology transfer deal with GSK for 'Grabody-B' drug development platform, marking second-largest biotech agreement in South Korea

en.infomaxai.com/news/articleV

Guardian LimericksguardianLimerick
2025-02-05

There once was a Danish pharma star,
Whose weight-loss jab soared high and far,
Despite Trump's tariff threat,
Novo Nordisk isn't upset,
Confident in sales, they raise the bar.

theguardian.com/business/2025/

2024-10-09

By 2019 popular non prescription #heartburn #medication #Zantac was recalled from retail after it was found to contain an #antihistamine that blocks the release of stomach acid called N-nitrosodimethylamine (#NDMA) that is linked to causing #cancer.

#Drug Mfgr #GSK has reached $2.2bn #legalsettlement in US that is supposed to cover 93% of user cases brought thus far.

Previously #GlaxoSmithKline had paid $70m to settle with the lab that discovered the issue, and other big #drugmakers that also marketed the #OTC drug, including #Pfizer and #Sanofi, have already reached sizable settlements.

on.ft.com/4eBVq5g #FinancialTimes #GiftLink #Legal #ProductLiability

GSK reaches $2.2bn heartburn OTC medication Zantac settlement will help resolve concerns hanging over the UK drugmaker GSK — The settlement covers 93% of all claimants  ( retail image of recalled product © Getty Images )
2024-10-04

«23andMe is on the brink. What happens to all its DNA data?»

npr.org/2024/10/03/g-s1-25795/

• 23andMe, a genetic testing company, is facing financial difficulties and its customers are concerned about the fate of their #genetic data.
• The company has collected genetic data from 15 million customers.
• There are concerns about the lack of federal protections for genetic data.
• 23andMe has an agreement with #GlaxoSmithKline to use customer data for drug development.

#privacyMatters #DNA #dataBreach

Dennis ADharmaDog
2023-10-04


ProPublica:
How a Big Pharma Company Stalled a Potentially Lifesaving Vaccine in Pursuit of Bigger Profits

"A vaccine against tuberculosis, the world’s deadliest infectious disease, has never been closer to reality, with the potential to save millions of lives. But its development slowed after its corporate owner focused on more profitable vaccines."
propublica.org/article/how-big

aparatorulaparatorul
2023-10-02

Țânțari modificați genetic înțeapă oamenii în cadrul unui test științific: "Mi s-a umflat tot antebrațul și am făcut bășici" bit.ly/45fzLKF

Dennis ADharmaDog
2023-09-28


The Guardian:
People with HIV offered hope of self-injected drug at home

"GSK-controlled company works on developing patient-administered treatment by end of the decade."
theguardian.com/business/2023/

Deutsche Welle (inoffiziell)deutschewelle@squeet.me
2022-04-21
Die Weltgesundheitsorganisation hat zum bevorstehenden internationalen Malaria-Tag eine positive Bilanz eines Pilotprojekts in Ghana, Kenia und Malawi vorgestellt. Und die Prognosen sehen noch besser aus.
WHO: Eine Million Kinder in Afrika gegen Malaria geimpft | DW | 21.04.2022
#Malaria #WHO #Impfstoff #TedrosAdhanomGhebreyesus #Afrika #GlaxoSmithKline #Mosquirix
heise online (inoffiziell)heiseonline@squeet.me
2022-03-08
Nach langer Entwicklung könnte die RTS,S oder Mosquirix genannte Vakzine auch zu Fortschritten bei der Bekämpfung anderer parasitärer Infektionen führen.​
Malaria und andere Parasiten-Infektionen: Gute Aussichten für neue Impfstoffe
2022-01-15

Knorr Fix für ?
---
RT @RND_de
Der für Marken wie Langnese, Knorr oder Pfanni bekannte Konsumgüterkonzern will im wachsen. Eine Sparte des Unternehmens (GSK) hat das Interesse des Weltkonzerns geweckt. rnd.de/wirtschaft/konsumgueter
twitter.com/RND_de/status/1482

Deutsche Welle (inoffiziell)deutschewelle@squeet.me
2021-10-12
Curevac zieht bei ihrem ersten Corona-Impfstoff die Reißleine. Stattdessen will die Tübinger Biotech-Firma mit einem Partner ein neues Vakzin auf Basis der mRNA-Technologie vorantreiben.
Curevac will neuen Corona-Impfstoff entwickeln | DW | 12.10.2021
#Curevac #Coronavirus #COVID-19 #Impfstoff #Vakzin #EMA #GlaxoSmithKline #Franz-WernerHaas
Deutsche Welle (inoffiziell)deutschewelle@squeet.me
2020-07-29
Auf das Medikament werden große Hoffnungen im Kampf gegen COVID-19 gesetzt. Nun hat auch die EU-Kommission zugegriffen. Eine zeitgleich vorgestellte Studie unterstreicht, wie bitter notwendig die Vorsorgebemühungen sind.
EU-Kommission sichert Bezug von Remdesivir für 30.000 Menschen | DW | 29.07.2020
#Corona #Impfstoff #Remdesivir #Veklury #Gilead #Sanofi #GlaxoSmithKline #Großbritannien #Studie #COVID-19
Hilal Bardakcıhilal@www.bilimma.com
2019-09-25

Kenya‘da sıtma aşıları uygulanmaya başlandı. Dünyanın ilk sıtma aşısı, daha önce Gana ve Malavi’de uygulanmıştı. Bu ay Kenya’nın bazı bölgelerinde de ilk sıtma aşısı uygulamaya konuldu. Sıtma aşısı Kenya’da rutin aşılama programına eklenecek. Önümüzdeki üç…

https://www.bilimma.com/kenyada-ilk-sitma-asilari-yapiliyor/

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst